SOMAZINA

This brand name is authorized in Ecuador, Spain, Hong Kong, Malta, Mexico

Active ingredients

The drug SOMAZINA contains one active pharmaceutical ingredient (API):

1 Citicoline UNII 536BQ2JVC7 - CITICOLINE

Citicoline stimulates the biosynthesis of structural phospholipids of the neuronal membrane. Citicoline, through this action, improves the function of the membrane mechanisms, such as the functioning of the ionic exchange pumps and receptors inserted in the latter, the modulation of which is indispensable in the neurotransmission. Read about Citicoline

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SOMAZINA Oral solution	Medicines Authority (MT)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06BX06	Citicoline	N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BX Other psychostimulants and nootropics
Discover more medicines within N06BX06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 17.375-2-04-04, 17.378-2-05-03, 17.379-2-04-03, 27.266-09-06, 28910-06-09
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 53168, 54389, 54390, 69416
Country: HK	Department of Health Drug Office	Identifier(s): 65122
Country: MT	Medicines Authority	Identifier(s): MA130/00201
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 344M2003, 508M2003